Connection

Torsten Zuberbier to Humans

This is a "connection" page, showing publications Torsten Zuberbier has written about Humans.
Connection Strength

0.190
  1. [Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)]. Laryngorhinootologie. 2020 10; 99(10):676-679.
    View in: PubMed
    Score: 0.007
  2. Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care? J Allergy Clin Immunol Pract. 2019 Nov - Dec; 7(8):2511-2523.
    View in: PubMed
    Score: 0.007
  3. Reply to Wood et al. Allergy. 2019 02; 74(2):418-419.
    View in: PubMed
    Score: 0.006
  4. Yin-Yang of IL-33 in Human Skin Mast Cells: Reduced Degranulation, but Augmented Histamine Synthesis through p38 Activation. J Invest Dermatol. 2019 07; 139(7):1516-1525.e3.
    View in: PubMed
    Score: 0.006
  5. New biologics in the treatment of urticaria. Curr Opin Allergy Clin Immunol. 2018 10; 18(5):425-431.
    View in: PubMed
    Score: 0.006
  6. MRGPRX2 is negatively targeted by SCF and IL-4 to diminish pseudo-allergic stimulation of skin mast cells in culture. Exp Dermatol. 2018 11; 27(11):1298-1303.
    View in: PubMed
    Score: 0.006
  7. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018 07; 73(7):1393-1414.
    View in: PubMed
    Score: 0.006
  8. A Comparison of the United States and International Perspective on Chronic Urticaria Guidelines. J Allergy Clin Immunol Pract. 2018 Jul - Aug; 6(4):1144-1151.
    View in: PubMed
    Score: 0.006
  9. Gastritis Can Cause and Trigger Chronic Spontaneous Urticaria Independent of the Presence of Helicobacter pylori. Int Arch Allergy Immunol. 2018; 175(4):246-251.
    View in: PubMed
    Score: 0.006
  10. Burden of chronic urticaria relative to psoriasis in five European countries. J Eur Acad Dermatol Venereol. 2018 Feb; 32(2):282-290.
    View in: PubMed
    Score: 0.006
  11. Allergic FceRI- and pseudo-allergic MRGPRX2-triggered mast cell activation routes are independent and inversely regulated by SCF. Allergy. 2018 Jan; 73(1):256-260.
    View in: PubMed
    Score: 0.006
  12. Alternative treatments for chronic spontaneous urticaria beyond the guideline algorithm. Curr Opin Allergy Clin Immunol. 2017 Aug; 17(4):278-285.
    View in: PubMed
    Score: 0.006
  13. Skin allergy. Curr Opin Allergy Clin Immunol. 2017 08; 17(4):262.
    View in: PubMed
    Score: 0.006
  14. Work productivity in rhinitis using cell phones: The MASK pilot study. Allergy. 2017 Oct; 72(10):1475-1484.
    View in: PubMed
    Score: 0.006
  15. Retinoic Acid Negatively Impacts Proliferation and MCTC Specific Attributes of Human Skin Derived Mast Cells, but Reinforces Allergic Stimulability. Int J Mol Sci. 2017 Feb 28; 18(3).
    View in: PubMed
    Score: 0.006
  16. Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy. J Eur Acad Dermatol Venereol. 2017 May; 31(5):761-773.
    View in: PubMed
    Score: 0.006
  17. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy. 2017 Jun; 72(6):857-865.
    View in: PubMed
    Score: 0.006
  18. Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy. 2011 Apr; 66(4):458-68.
    View in: PubMed
    Score: 0.004
  19. Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy. 2011 Mar; 66(3):317-30.
    View in: PubMed
    Score: 0.004
  20. EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy. 2006 Mar; 61(3):321-31.
    View in: PubMed
    Score: 0.003
  21. Bivalent effect of UV light on human skin mast cells-low-level mediator release at baseline but potent suppression upon mast cell triggering. J Invest Dermatol. 2005 Feb; 124(2):453-6.
    View in: PubMed
    Score: 0.002
  22. [Screening procedures in the family practice. What is the new fast allergy test?]. MMW Fortschr Med. 2004 Oct 28; 146(44):16.
    View in: PubMed
    Score: 0.002
  23. Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report. Allergy. 2021 12; 76(12):3589-3612.
    View in: PubMed
    Score: 0.002
  24. Management of anaphylaxis due to COVID-19 vaccines in the elderly. Allergy. 2021 10; 76(10):2952-2964.
    View in: PubMed
    Score: 0.002
  25. Inhaled corticosteroids in early COVID-19-A tale of many facets. Allergy. 2021 11; 76(11):3540-3542.
    View in: PubMed
    Score: 0.002
  26. ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper. Allergy. 2021 06; 76(6):1624-1628.
    View in: PubMed
    Score: 0.002
  27. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2 LEN consensus. Allergy. 2021 08; 76(8):2354-2366.
    View in: PubMed
    Score: 0.002
  28. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper. Allergy. 2021 03; 76(3):648-676.
    View in: PubMed
    Score: 0.002
  29. Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19. Int Arch Allergy Immunol. 2021; 182(4):324-338.
    View in: PubMed
    Score: 0.002
  30. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria. Allergy. 2021 03; 76(3):816-830.
    View in: PubMed
    Score: 0.002
  31. Spices to Control COVID-19 Symptoms: Yes, but Not Only…. Int Arch Allergy Immunol. 2021; 182(6):489-495.
    View in: PubMed
    Score: 0.002
  32. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. Allergy. 2020 10; 75(10):2440-2444.
    View in: PubMed
    Score: 0.002
  33. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020). Allergy. 2021 03; 76(3):689-697.
    View in: PubMed
    Score: 0.002
  34. Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19. Allergy. 2021 03; 76(3):735-750.
    View in: PubMed
    Score: 0.002
  35. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy. 2020 07; 75(7):1546-1554.
    View in: PubMed
    Score: 0.002
  36. Olaparib Desensitization in a Patient with Recurrent Peritoneal Cancer. N Engl J Med. 2018 11 29; 379(22):2176-2177.
    View in: PubMed
    Score: 0.002
  37. Role of nonallergic hypersensitivity reactions in children with chronic urticaria. Allergy. 1998 Nov; 53(11):1074-7.
    View in: PubMed
    Score: 0.002
  38. Noninvasive measures in atopic dermatitis. Curr Opin Allergy Clin Immunol. 2018 10; 18(5):417-424.
    View in: PubMed
    Score: 0.002
  39. Reply to Ensina et al. Pediatr Allergy Immunol. 2018 09; 29(6):670-671.
    View in: PubMed
    Score: 0.002
  40. Updosing of bilastine is effective in moderate to severe chronic spontaneous urticaria: A real-life study. Allergy. 2018 10; 73(10):2073-2075.
    View in: PubMed
    Score: 0.002
  41. Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients. Pediatr Allergy Immunol. 2018 09; 29(6):630-636.
    View in: PubMed
    Score: 0.002
  42. Kinetics and tissue repair process following fractional bipolar radiofrequency treatment. J Cosmet Laser Ther. 2019; 21(2):71-75.
    View in: PubMed
    Score: 0.002
  43. Chronic urticaria - What does the new guideline tell us? J Dtsch Dermatol Ges. 2018 May; 16(5):584-593.
    View in: PubMed
    Score: 0.002
  44. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study. Allergy. 2018 08; 73(8):1622-1631.
    View in: PubMed
    Score: 0.002
  45. Benefit of mepolizumab treatment in a patient with chronic spontaneous urticaria. J Dtsch Dermatol Ges. 2018 Apr; 16(4):477-478.
    View in: PubMed
    Score: 0.002
  46. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study. Allergy. 2018 09; 73(9):1763-1774.
    View in: PubMed
    Score: 0.002
  47. Development and validation of the Cholinergic Urticaria Quality-of-Life Questionnaire (CholU-QoL). Clin Exp Allergy. 2018 04; 48(4):433-444.
    View in: PubMed
    Score: 0.002
  48. Chronic inducible urticaria: A systematic review of treatment options. J Allergy Clin Immunol. 2018 05; 141(5):1726-1734.
    View in: PubMed
    Score: 0.002
  49. Lymphocyte surface markers and cytokines are suitable for detection and potency assessment of skin-sensitizing chemicals in an in vitro model of allergic contact dermatitis: the LCSA-ly. Arch Toxicol. 2018 Apr; 92(4):1495-1505.
    View in: PubMed
    Score: 0.002
  50. Development of tripe palms and soles in a patient with long pre-existing systemic mastocytosis and newly developed non-small cell lung cancer. J Eur Acad Dermatol Venereol. 2018 Apr; 32(4):e151-e153.
    View in: PubMed
    Score: 0.001
  51. Evanescence wave-based technology for the rapid and sensitive quantification of biological analytes. J Allergy Clin Immunol. 2018 02; 141(2):817-820.e5.
    View in: PubMed
    Score: 0.001
  52. Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticaria. J Eur Acad Dermatol Venereol. 2018 Mar; 32(3):e112-e113.
    View in: PubMed
    Score: 0.001
  53. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study. Allergy. 2018 02; 73(2):505-510.
    View in: PubMed
    Score: 0.001
  54. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis. Rhinology. 2017 Sep 01; 55(3):202-210.
    View in: PubMed
    Score: 0.001
  55. The Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire Using Mobile Technology: The MASK Study. J Investig Allergol Clin Immunol. 2018; 28(1):42-44.
    View in: PubMed
    Score: 0.001
  56. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project). Allergy. 2018 Jan; 73(1):77-92.
    View in: PubMed
    Score: 0.001
  57. An efficient method for gene knock-down by RNA interference in human skin mast cells. Exp Dermatol. 2017 11; 26(11):1136-1139.
    View in: PubMed
    Score: 0.001
  58. Responsiveness and minimal important difference of the urticaria control test. J Allergy Clin Immunol. 2017 12; 140(6):1710-1713.e11.
    View in: PubMed
    Score: 0.001
  59. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017 Oct; 140(4):950-958.
    View in: PubMed
    Score: 0.001
  60. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017 Sep; 72(9):1297-1305.
    View in: PubMed
    Score: 0.001
  61. Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper. Allergy. 2017 Jul; 72(7):1035-1042.
    View in: PubMed
    Score: 0.001
  62. Spatial distribution of allergenic pollen through a large metropolitan area. Environ Monit Assess. 2017 Apr; 189(4):169.
    View in: PubMed
    Score: 0.001
  63. Google Trends terms reporting rhinitis and related topics differ in European countries. Allergy. 2017 Aug; 72(8):1261-1266.
    View in: PubMed
    Score: 0.001
  64. Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes. J Allergy Clin Immunol. 2017 02; 139(2):388-399.
    View in: PubMed
    Score: 0.001
  65. Adaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL). J Dermatol Sci. 2011 Apr; 62(1):36-41.
    View in: PubMed
    Score: 0.001
  66. Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study. Int Arch Allergy Immunol. 2010; 153(4):395-402.
    View in: PubMed
    Score: 0.001
  67. Occupational contact dermatitis from ninhydrin in a police officer. Contact Dermatitis. 2010 Jan; 62(1):59-60.
    View in: PubMed
    Score: 0.001
  68. Muckle-Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred. Br J Dermatol. 2004 Jul; 151(1):99-104.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.